CN112401234A - 一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐 - Google Patents
一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐 Download PDFInfo
- Publication number
- CN112401234A CN112401234A CN202011396178.4A CN202011396178A CN112401234A CN 112401234 A CN112401234 A CN 112401234A CN 202011396178 A CN202011396178 A CN 202011396178A CN 112401234 A CN112401234 A CN 112401234A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- combined
- combined meal
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000012054 meals Nutrition 0.000 title claims abstract description 58
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 19
- 208000008589 Obesity Diseases 0.000 title claims abstract description 14
- 235000020824 obesity Nutrition 0.000 title claims abstract description 14
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 9
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 36
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 32
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 28
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229960000304 folic acid Drugs 0.000 claims abstract description 18
- 235000019152 folic acid Nutrition 0.000 claims abstract description 18
- 239000011724 folic acid Substances 0.000 claims abstract description 18
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 16
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 16
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 16
- 241000251511 Holothuroidea Species 0.000 claims abstract description 16
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 16
- 229960003080 taurine Drugs 0.000 claims abstract description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 240000000249 Morus alba Species 0.000 claims abstract description 14
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 14
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 14
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 14
- 239000011718 vitamin C Substances 0.000 claims abstract description 14
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 10
- 240000007087 Apium graveolens Species 0.000 claims abstract description 8
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims abstract description 8
- 235000010591 Appio Nutrition 0.000 claims abstract description 8
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 8
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 8
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 8
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 8
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 8
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 8
- 229920002752 Konjac Polymers 0.000 claims abstract description 8
- 241001668545 Pascopyrum Species 0.000 claims abstract description 8
- 244000197580 Poria cocos Species 0.000 claims abstract description 8
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 8
- 244000300264 Spinacia oleracea Species 0.000 claims abstract description 8
- 235000009337 Spinacia oleracea Nutrition 0.000 claims abstract description 8
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 8
- 229930003944 flavone Natural products 0.000 claims abstract description 8
- 150000002212 flavone derivatives Chemical class 0.000 claims abstract description 8
- 235000011949 flavones Nutrition 0.000 claims abstract description 8
- 235000010485 konjac Nutrition 0.000 claims abstract description 8
- 229960005375 lutein Drugs 0.000 claims abstract description 8
- 235000012680 lutein Nutrition 0.000 claims abstract description 8
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 8
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 8
- 239000001656 lutein Substances 0.000 claims abstract description 8
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 8
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 8
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 8
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 7
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 7
- 102000004407 Lactalbumin Human genes 0.000 claims abstract description 6
- 108090000942 Lactalbumin Proteins 0.000 claims abstract description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 4
- 241000628997 Flos Species 0.000 claims abstract description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 4
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 4
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 4
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 4
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960002477 riboflavin Drugs 0.000 claims abstract description 4
- 229960003495 thiamine Drugs 0.000 claims abstract description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 4
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 4
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 4
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 4
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 4
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 4
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 4
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 4
- 229930003270 Vitamin B Natural products 0.000 claims description 12
- 235000019156 vitamin B Nutrition 0.000 claims description 12
- 239000011720 vitamin B Substances 0.000 claims description 12
- 229940088594 vitamin Drugs 0.000 claims description 11
- 229930003231 vitamin Natural products 0.000 claims description 11
- 235000013343 vitamin Nutrition 0.000 claims description 11
- 239000011782 vitamin Substances 0.000 claims description 11
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 11
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 8
- 102000007544 Whey Proteins Human genes 0.000 claims description 8
- 108010046377 Whey Proteins Proteins 0.000 claims description 8
- 150000001720 carbohydrates Chemical class 0.000 claims description 8
- 235000014633 carbohydrates Nutrition 0.000 claims description 8
- 235000021119 whey protein Nutrition 0.000 claims description 8
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 6
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 6
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 6
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 6
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 6
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 6
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 6
- 240000000171 Crataegus monogyna Species 0.000 claims description 6
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 6
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 6
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 6
- 235000021307 Triticum Nutrition 0.000 claims description 6
- 240000004922 Vigna radiata Species 0.000 claims description 6
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims description 6
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims description 6
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 235000013557 nattō Nutrition 0.000 claims description 5
- 229940026314 red yeast rice Drugs 0.000 claims description 5
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 4
- 235000019766 L-Lysine Nutrition 0.000 claims description 4
- 244000241838 Lycium barbarum Species 0.000 claims description 4
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 4
- 235000015468 Lycium chinense Nutrition 0.000 claims description 4
- 239000004472 Lysine Substances 0.000 claims description 4
- 108010001441 Phosphopeptides Proteins 0.000 claims description 4
- 239000005018 casein Substances 0.000 claims description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 4
- 235000021240 caseins Nutrition 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 3
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 239000008280 blood Substances 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 27
- 210000004185 liver Anatomy 0.000 description 13
- 230000000694 effects Effects 0.000 description 9
- 230000036772 blood pressure Effects 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 8
- 208000004930 Fatty Liver Diseases 0.000 description 7
- 206010019708 Hepatic steatosis Diseases 0.000 description 7
- 208000010706 fatty liver disease Diseases 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 231100000240 steatosis hepatitis Toxicity 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000209140 Triticum Species 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 4
- 229960002079 calcium pantothenate Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 206010022489 Insulin Resistance Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 229940086319 nattokinase Drugs 0.000 description 3
- 108010073682 nattokinase Proteins 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 229930003571 Vitamin B5 Natural products 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 231100000234 hepatic damage Toxicity 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000007235 immunity generation Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000008818 liver damage Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 230000002537 thrombolytic effect Effects 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 235000009492 vitamin B5 Nutrition 0.000 description 2
- 239000011675 vitamin B5 Substances 0.000 description 2
- 206010048781 Accessory kidney Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000025309 Hair disease Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 240000002624 Mespilus germanica Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical group C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000034653 disorder of pilosebaceous unit Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical class C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 239000003987 organophosphate pesticide Substances 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003845 vascular endothelial function Effects 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐，括三个组合代餐，第一个组合代餐配方为：燕麦、海参、乳清蛋白、海带、小麦草、芹菜、菠菜、苦荞、薏茨仁、魔芋、桑叶、山药、茯苓、葛根、肉桂、牛磺酸、维生素Ｃ；第二个组合代餐配方为：枸杞子、酸枣仁、菊花、桑椹子、绿豆、纳豆、红曲米、山楂、磷脂、叶酸；第三个组合代餐配方为：苦荞黄酮、海参、肉桂、黄精、叶黄素、牛磺酸、叶酸、维生素C、维生素B1、维生素B2、维生素B6、维生素B12。
Description
技术领域
本发明涉及调理食品领域，尤其是涉及一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐。
背景技术
大米、小麦含有丰富的植物脂肪、蛋白质、维生素、矿物质、膳食纤维，这些成份存在于表皮上，由于人们追求口感经精加工后，上述五类营养素损失80%以上，因此，精大米精面只含碳水化合物。精面、精白米饭是营养单一的食品，接近垃圾食品。
发明内容
本发明为克服上述情况不足，旨在提供一种能解决上述问题的技术方案。
一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐，包括三个组合代餐，第一个组合代餐配方为：燕麦、海参、乳清蛋白、海带、小麦草、芹菜、菠菜、苦荞、薏茨仁、魔芋、桑叶、山药、茯苓、葛根、肉桂、牛磺酸、维生素Ｃ；
第二个组合代餐配方为：枸杞子、酸枣仁、菊花、桑椹子、绿豆、纳豆、红曲米、山楂、磷脂、叶酸；
第三个组合代餐配方为：苦荞黄酮、海参、肉桂、黄精、叶黄素、牛磺酸、叶酸、维生素C、维生素B1、维生素B2、维生素B6、维生素B12。
作为本发明进一步的方案：第一个组合代餐的配方重量配比为：燕麦80-100份、海参10-15份、乳清蛋白5-8份、海带3-5份、小麦草10-20份、芹菜10-15份、菠菜10-20份、苦荞10-15份、薏茨仁20-25份、魔芋5-10份、桑叶3-5份、山药5-8份、茯苓3-4份、葛根1-2份、肉桂5-8份、牛磺酸1-2份、维生素Ｃ5-6份。
作为本发明进一步的方案：第二个组合代餐的配方重量配比为：枸杞子10-15份、酸枣仁5-8份、菊花5-10份、桑椹子3-5份、绿豆20-30份、纳豆10-15份、红曲米50-80份、山楂5-10份、磷脂5-8份、叶酸3-5份。
作为本发明进一步的方案：第二个组合代餐配方还包括以下重量配比原材料：小麦苗5-10份、乳清蛋白20-25份、酵母3-5份、L-赖氨酸1-3份、酪蛋白磷酸肽1-3份。
作为本发明进一步的方案：第三个组合代餐的配方重量配比为：苦荞黄酮20-23份、海参10-15份、肉桂5-10份、黄精3-5份、叶黄素3-5份、牛磺酸2-3份、叶酸2-5份、维生素C10-15份、维生素B1 3-5份、维生素B2 2-3份、维生素B6 2-3份、维生素B12 3-5份。
与现有技术相比，本发明的有益效果是：通过科学营养成分的配制加工，减少了碳水化合物的摄入量、增加膳食纤维及蛋白质等物质的含量来改变患者的饮食结构，能减轻患者体重、改善胰岛素抵抗，对血糖、血脂及尿酸、血压均有不同程度的益处。同时配合生活方式的管理，可以达到使血糖、血压、血脂长期稳定的目的，减少患者用药，减轻了患者及医保的负担。其食用方便，价格合理，主要适合用于肥胖及糖尿病等代谢综合征患者代替部分主食。
本发明的附加方面和优点将在下面的描述中部分给出，部分将从下面的描述中变得明显，或通过本发明的实践了解到。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
本发明实施例中，一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐，包括三个组合代餐，第一个组合代餐配方为：燕麦、海参、乳清蛋白、海带、小麦草、芹菜、菠菜、苦荞、薏茨仁、魔芋、桑叶、山药、茯苓、葛根、肉桂、牛磺酸、维生素Ｃ；
第一个组合代餐的配方重量配比为：燕麦80-100份、海参10-15份、乳清蛋白5-8份、海带3-5份、小麦草10-20份、芹菜10-15份、菠菜10-20份、苦荞10-15份、薏茨仁20-25份、魔芋5-10份、桑叶3-5份、山药5-8份、茯苓3-4份、葛根1-2份、肉桂5-8份、牛磺酸1-2份、维生素Ｃ5-6份。
第一个组合代餐其核心指标为：
第一个组合代餐减少了碳水化合物，增加了膳食纤维及优质蛋白质，改善胰岛素抵抗，减轻体重、稳定血糖、血脂。
第二个组合代餐配方为：枸杞子、酸枣仁、菊花、桑椹子、绿豆、纳豆、红曲米、山楂、磷脂、叶酸；
第二个组合代餐的配方重量配比为：枸杞子10-15份、酸枣仁5-8份、菊花5-10份、桑椹子3-5份、绿豆20-30份、纳豆10-15份、红曲米50-80份、山楂5-10份、磷脂5-8份、叶酸3-5份。
其中：
枸杞子：滋补肝肾，益精明目。用于虚劳精亏，历代医家常用于治疗肝血不足、肾阴亏虚引起的视物不清和夜盲症。
酸枣仁：具有养肝、宁心、安神、敛汗的功用。
菊花：疏风清热；清肝明目；解毒消肿；眼目昏花。
桑椹子：中医认为，肝主藏血、肾主生髓，桑椹子入肝、肾经，具有 “滋肝肾，充血液，祛风湿，健步履，熄虚风，清虚火”，可以治疗肝肾阴虚所致的头晕目眩、耳鸣盗汗。
绿豆：绿豆可解酒毒、野菌毒、砒霜毒、有机磷农药毒、铅毒、丹石毒、鼠药毒等。绿豆含丰富胰蛋白酶抑制剂，抗肿瘤、保肝护肾。
泛酸钙 (维生素B5)：参与蛋白质、脂肪、糖在体内的代谢。缺乏泛酸钙症状:生长停止,体重减少,突然死亡，皮肤、毛发障碍，神经系统障碍，消化器官失常,肝功能障碍，影响抗体形成，副肾障碍。维生素B5是人体维持正常生理不可缺少的。
纳豆：
1.纳豆激酶能直接分解血栓，具有强大的溶栓作用，是唯一口服速效的溶栓食品，“预防心脏病”的效果已经得到美国FDA的认可。
2.纳豆激酶降低血粘度，清理血管内壁的中性脂肪，使血管通畅、弹性增加，血液循环加速，从而能有效、平稳地降低血压。
3. 纳豆激酶抗氧化能力特别强，是维生素C的20倍、维生素E的50倍。超强的抗氧化作用保持微细血管的畅通，延缓衰老和预防老年痴呆症。
红曲米：红麴至少可产生10种莫那可林K系列物质，除了降低胆固醇外，还有清血、排毒、降血糖、降血压、抗衰老。心脏病与高血脂相关脂肪肝等疾病。
山楂：降压降脂，杀菌消炎。促进消化，活血化瘀，防治心血管疾病，降低血压和胆固醇、软化血管。山楂是很好的保肝食品，
磷脂：磷脂对活化细胞，维持新陈代谢，基础代谢及荷尔蒙的均衡分泌，增强人体的免疫力和再生力，磷脂可以分解过高的血脂和胆固醇，被公认为“血管清道夫”，调节肝代谢功能。
叶酸：叶酸可改善血管内皮功能、预防心血管疾病。
第二个组合代餐可以有效的
1、纠正代谢、恢复部分胰岛功能
2、补充肝脏所需营养，增强肝脏的代谢功能、免疫功能、再生功能。
3、保护心脑血管、有溶栓、降脂、降压、扩氧化、清除自由基作用。
4、降血糖、血脂、血压、尿酸，减肥、减轻胰岛素抵抗。
第三个组合代餐配方为：苦荞黄酮、海参、肉桂、黄精、叶黄素、牛磺酸、叶酸、维生素C、维生素B1、维生素B2、维生素B6、维生素B12。
第三个组合代餐的配方重量配比为：苦荞黄酮20-23份、海参10-15份、肉桂5-10份、黄精3-5份、叶黄素3-5份、牛磺酸2-3份、叶酸2-5份、维生素C10-15份、维生素B1 3-5份、维生素B2 2-3份、维生素B6 2-3份、维生素B12 3-5份。
第三个组合代餐可以有效的：改善微血管循环、逆转心脑血管病变、视网膜病变、肾脏病变、神经性病变等糖尿病并发症。
【实施例一】
一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐，包括三个组合代餐，第一个组合代餐的配方重量配比为：燕麦80份、海参10份、乳清蛋白5份、海带3份、小麦草20份、芹菜15份、菠菜20份、苦荞15份、薏茨仁25份、魔芋10份、桑叶5份、山药8份、茯苓4份、葛根2份、肉桂8份、牛磺酸1份、维生素Ｃ5份。
第二个组合代餐的配方重量配比为：枸杞子15份、酸枣仁18份、菊花10份、桑椹子3份、绿豆20份、纳豆10份、红曲米50份、山楂5份、磷脂5份、叶酸3份。
第三个组合代餐的配方重量配比为：苦荞黄酮23份、海参15份、肉桂10份、黄精3份、叶黄素3份、牛磺酸2份、叶酸5份、维生素C15份、维生素B1 5份、维生素B2 3份、维生素B63份、维生素B12 5份。
【实施例二】
根据实施例一所述的，在第二个组合代餐中，当患者存在因糖尿病引起的肝脏受损时；
第二个组合代餐配方还可包括以下重量配比原材料：小麦苗5-10份、乳清蛋白20-25份、酵母3-5份、L-赖氨酸1-3份、酪蛋白磷酸肽1-3份，该组份为补充组份，用于因糖尿病引起的肝脏受损提供自我修复所需要的营养。
该配方为补充代餐，根据患者的自身情况进行选择使用；
其中：
小麦苗：主要成份是叶绿素，有清肝、清血作用，抑制癌细胞滋生、其丰富的碱性物质改善酸性体液，是肝脏、心脏、及血液的保卫神。
乳清蛋白：丰富的蛋白质可修复受损肝。乳清蛋白属于优质的完全蛋白质，含有人体必需的8种氨基酸，含有β-乳球蛋白、α-乳白蛋白、免疫球蛋白，是人体生长、发育、抗衰老、骨骼健康等生命活动不可缺少的精华物质，
酵母：酵母是一种营养丰富的单细胞微生物，被称为“取之不尽的营养源”。除了含丰富的维生素B族群、硒、铬外，还有蛋白质、多种维生素矿物质和酶类。保护肝脏，抗衰老、抗肿瘤、抗动脉硬化
L-赖氨酸：提高智力、促进生长、增强体质；增进食欲、改善失眠，提高记忆力、帮助产生抗体、激素和酶，提高免疫力、增加血色素、帮助钙的吸收、降低甘油三酯，预防心脑血管疾病的产生。
酪蛋白磷酸肽(CPP)：有效提高人体钙、铁、锌等二价矿物质的摄入量以及吸收和利用率，有固齿、健齿、修复龈齿的作用。
对于本领域技术人员而言，显然本发明不限于上述示范性实施例的细节，而且在不背离本发明的精神或基本特征的情况下，能够以其他的具体形式实现本发明。因此，无论从哪一点来看，均应将实施例看作是示范性的，而且是非限制性的，本发明的范围由所附权利要求而不是上述说明限定，因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
【实施例三】
1、实验目的：观察三个组合代餐对糖尿病合并肥胖患者的临床作用。
2、实验方法: 将我院门诊或者住院部的120例符合入组标准的患者随机分为观察组和对照组，每组60例。观察组：三餐时服用第一、二、三组代餐各一份，以代替主食，进食菜和以前不变。对照组：饮食习惯维持不变。两组药物及其它生活习惯不变。观察两组治疗前后的血糖、血脂及体重等变化情况。
3、两组治疗前在性别、年龄、身高、病程等指标比较差别无统计学意义（ P >0.05），具有可比性。具体如表3.1）
表3.1 各组治疗前性别、年龄、身高、病程指标比较（x ± s）
3.2两组病人干预前后血糖及血脂控制情况比较(见下表)
表 3.2.1 两组病人干预前后血糖及血脂控制情况比较 (x ± s)
表 3.2.2 两组病人干预前后体重、体重指数、腰围控制情况比较 (x ± s)
4、结论：可明显降低患者体重、腹围， 改善血脂相关指标、降低血糖、改善胰岛素。
【实施例四】
1、实验目的：观察第二个组合代餐对糖尿病合并脂肪肝的作用。
2、实验方法: 将我院门诊或者住院部的60例糖尿病合并脂肪肝的患者入组，给予第二个组合代餐治疗，其余生活方式不变。观察治疗前后脂肪肝的变化情况。
表4.1 第二个组合代餐对糖尿病患者脂肪肝的影响（病例数60）
与治疗前比较，**p<0.05
3、结论：第二个组合代餐可以改善脂肪肝的严重程度，减轻脂肪肝。
Claims (5)
1.一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐，其特征在于，包括三个组合代餐，第一个组合代餐配方为：燕麦、海参、乳清蛋白、海带、小麦草、芹菜、菠菜、苦荞、薏茨仁、魔芋、桑叶、山药、茯苓、葛根、肉桂、牛磺酸、维生素Ｃ；
第二个组合代餐配方为：枸杞子、酸枣仁、菊花、桑椹子、绿豆、纳豆、红曲米、山楂、磷脂、叶酸；
第三个组合代餐配方为：苦荞黄酮、海参、肉桂、黄精、叶黄素、牛磺酸、叶酸、维生素C、维生素B1、维生素B2、维生素B6、维生素B12。
2.根据权利要求1所述的一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐，其特征在于，第一个组合代餐的配方重量配比为：燕麦80-100份、海参10-15份、乳清蛋白5-8份、海带3-5份、小麦草10-20份、芹菜10-15份、菠菜10-20份、苦荞10-15份、薏茨仁20-25份、魔芋5-10份、桑叶3-5份、山药5-8份、茯苓3-4份、葛根1-2份、肉桂5-8份、牛磺酸1-2份、维生素Ｃ5-6份。
3.根据权利要求1所述的一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐，其特征在于，第二个组合代餐的配方重量配比为：枸杞子10-15份、酸枣仁5-8份、菊花5-10份、桑椹子3-5份、绿豆20-30份、纳豆10-15份、红曲米50-80份、山楂5-10份、磷脂5-8份、叶酸3-5份。
4.根据权利要求3所述的一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐，其特征在于，第二个组合代餐配方还包括以下重量配比原材料：小麦苗5-10份、乳清蛋白20-25份、酵母3-5份、L-赖氨酸1-3份、酪蛋白磷酸肽1-3份。
5.根据权利要求1所述的一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐，其特征在于，第三个组合代餐的配方重量配比为：苦荞黄酮20-23份、海参10-15份、肉桂5-10份、黄精3-5份、叶黄素3-5份、牛磺酸2-3份、叶酸2-5份、维生素C10-15份、维生素B1 3-5份、维生素B2 2-3份、维生素B6 2-3份、维生素B12 3-5份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011396178.4A CN112401234A (zh) | 2020-12-03 | 2020-12-03 | 一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011396178.4A CN112401234A (zh) | 2020-12-03 | 2020-12-03 | 一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112401234A true CN112401234A (zh) | 2021-02-26 |
Family
ID=74829972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011396178.4A Pending CN112401234A (zh) | 2020-12-03 | 2020-12-03 | 一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112401234A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114568626A (zh) * | 2022-03-16 | 2022-06-03 | 广州健力园生物科技有限公司 | 一种餐后血糖不升高的代餐粉及其制备方法 |
-
2020
- 2020-12-03 CN CN202011396178.4A patent/CN112401234A/zh active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114568626A (zh) * | 2022-03-16 | 2022-06-03 | 广州健力园生物科技有限公司 | 一种餐后血糖不升高的代餐粉及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102813753B (zh) | 含有苁蓉或锁阳与菊花、牛磺酸、番茄红素、叶黄素、β-胡萝卜素组合的组合物 | |
| CN101744170B (zh) | 一种适于糖尿病人的苦荞八宝粥及其制作方法 | |
| CN102524659A (zh) | 一种具有营养保健功能的粮食配方 | |
| CN108323719A (zh) | 一种具有补肾乌发功能的黑色杂粮粉 | |
| CN103609696A (zh) | 一种益智明目型酸奶及加工方法 | |
| CN1802934A (zh) | 糖尿病食疗营养面包饼 | |
| CN103919227B (zh) | 一种具有增强记忆力作用的玉米低聚肽饮料及其生产工艺 | |
| CN101366521B (zh) | 天然型功能食品 | |
| CN101077186A (zh) | 蛋白醋液 | |
| CN102138590B (zh) | 一种三豆复合植物蛋白饮料及其制备方法 | |
| CN112401234A (zh) | 一种预防及调理糖尿病及肥胖的低碳水化合物组合代餐 | |
| CN103598635A (zh) | 一种护眼速食汤及其制作工艺 | |
| CN104957624A (zh) | 一种人体植物配方保健品 | |
| CN104222287A (zh) | 一种能抗疲劳防衰老的保健牛奶及其制备方法 | |
| CN106954786A (zh) | 杂粮粉及其制备方法 | |
| CN116686876A (zh) | 一种提高注意力的儿童配方奶粉及其制备方法 | |
| CN107258915B (zh) | 一种蛹虫草玉米花生复合饮料 | |
| CN107279445A (zh) | 一种纠正人体亚健康状态的口香糖配方和生产工艺 | |
| CN103549600A (zh) | 一种纯天然营养免疫保健饮料的配制方法 | |
| CN113749152A (zh) | 一种健康养生强身饮品及其制备方法 | |
| CN106234896A (zh) | 一种治疗肾病的保健饮品及其制备方法 | |
| CN105831735A (zh) | 藜麦婴幼儿超级营养粉 | |
| CN106036384A (zh) | 一种适合糖尿病患者食用的养生粥及其制备方法 | |
| CN111196983A (zh) | 一种谷物保健酒及制备方法 | |
| CN1562253A (zh) | 一种用于改善女性更年期症状的保健食品及其制作方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210226 |